Literature DB >> 19034932

Cutaneous melanoma in Asian-Americans.

Susanna Shin1, Bryan E Palis, Jerri Linn Phillips, Andrew K Stewart, Roger R Perry.   

Abstract

BACKGROUND: There is little information available on melanoma in non-white populations. Our objective was to characterize melanoma in Asian-Americans (AsA) and compare patient demographics and tumor characteristics with the non-Hispanic White (NHW) population.
METHODS: 483,050 cutaneous melanoma patients diagnosed between 1986 and 2005 were identified using the National Cancer Data Base (NCDB); 1,237 were AsA, and 409,564 were NHW. Age, gender, site, histologic type, tumor thickness, AJCC stage, and survival were compared.
RESULTS: AsA were more likely to be diagnosed with acral lentiginous tumors (6.7%) than NHW (0.8%, P < 0.001). A greater proportion of AsA were diagnosed with T4 tumors (15.6%) than NHW (8.5%, P < 0.001). AsA presented with fewer early stage I-II tumors and more late stage III-IV tumors than NHW (P < 0.001). Survival was similar for AsA and NHW.
CONCLUSIONS: This is the largest study to date on melanoma in AsA. Compared to NHW, AsA are more likely to have acral lentinginous tumors, thick tumors, and higher stage. Despite this, their survival is similar to the NHW population.

Entities:  

Mesh:

Year:  2009        PMID: 19034932     DOI: 10.1002/jso.21195

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Patient-reported frequency of acral surface inspection during skin examination in white and ethnic minority patients.

Authors:  Monica S Tsai; Melvin W Chiu
Journal:  J Am Acad Dermatol       Date:  2014-04-24       Impact factor: 11.527

2.  Coexistence of amelanotic melanoma and liposarcoma.

Authors:  Taek Jo Jeong; Eun Ju Lee; Sik Haw; Min Kyung Shin; Choong Rim Haw
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

3.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

4.  Cutaneous Spitzoid melanoma in a very young girl of Asian descent.

Authors:  Suzette G Miranda; Mohammed Kashani-Sabet; Daniel Zedek; Timothy H McCalmont; Stanley P L Leong
Journal:  BMJ Case Rep       Date:  2011-03-29

5.  Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities.

Authors:  Lindsay G Wich; Michelle W Ma; Leah S Price; Stanislav Sidash; Russell S Berman; Anna C Pavlick; George Miller; Umut Sarpel; Judith D Goldberg; Iman Osman
Journal:  J Community Health       Date:  2011-06

6.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

7.  Racial Differences in the Prognosis and Survival of Cutaneous Melanoma From 1990 to 2020 in North America: A Systematic Review and Meta-Analysis.

Authors:  Megan Lam; Jie Wei Zhu; Angie Hu; Jennifer Beecker
Journal:  J Cutan Med Surg       Date:  2021-10-22       Impact factor: 2.092

Review 8.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 9.  Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.